Is it time to give up with calcineurin inhibitors in kidney transplantation?

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 3, Issue 2

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Transplantation

ISSN

2220-3230

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Frontier

World J Transplant. Jun 24, 2013; 3(2): 7-25
Published online Jun 24, 2013. doi: 10.5500/wjt.v3.i2.7

Table 5 Glomerular filtration rate gain in different minimization trials

Study	Calcineurin inhibitors	Length	Glomerular filtration rate gain (mL/min)
US09	TAC	6 mo	+2.8
De Sevaux	CsA	6 mo	+4.0
CAESAR Study	CsA	12 mo	+2.3
SYMPHONY Study	TAC vs CsA	3 yr	+4.6
A2309	CsA	12 mo	+1.9
ASSET Study	TAC	12 mo	+5.3
B156	CsA	3 yr	+4.9
EVEREST	CsA	6 mo	+2.1

CsA: Cyclosporine; TAC: Tacrolimus.

Citation: Salvadori M, Bertoni E. Is it time to give up with calcineurin inhibitors in kidney transplantation? World J Transplant 2013; 3(2): 7-25
URL: https://www.wjgnet.com/2220-3230/full/v3/i2/7.htm
DOI: https://dx.doi.org/10.5500/wjt.v3.i2.7

Salvadori M, Bertoni E. Is it time to give up with calcineurin inhibitors in kidney transplantation? World J Transplant 2013; 3(2): 7-25 [PMID: 24175203 DOI: 10.5500/wjt.v3.i2.7]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.